Skip to main content
. 2021 Jun 7;134(13):1569–1575. doi: 10.1097/CM9.0000000000001415

Table 3.

First-line chemotherapy for de novo stage IV breast cancer (n = 387).

Chemotherapy regimen n (%)
Anthracyclines + paclitaxel 221 (51.7)
Paclitaxel 61 (15.7)
Paclitaxel + platinum 38 (9.8)
Capecitabine + paclitaxel 34 (8.9)
Cyclophosphamide + anthracyclines 21 (5.4)
Others 12 (3.1)